UnitedHealth Group (NYSE:UNH) had its target price raised by BMO Capital Markets from $14.50 to $275.00 in a report published on Wednesday morning. BMO Capital Markets currently has an outperform rating on the healthcare conglomerate’s stock.

UNH has been the subject of several other reports. Leerink Swann reissued a buy rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Zacks Investment Research raised shares of UnitedHealth Group from a hold rating to a buy rating and set a $219.00 price target for the company in a report on Thursday, September 21st. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group to $225.00 and gave the company an overweight rating in a report on Wednesday, October 18th. Oppenheimer raised their price target on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an outperform rating in a report on Wednesday, October 18th. Finally, Wells Fargo & Co reissued an outperform rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Three analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus target price of $241.30.

UnitedHealth Group (NYSE:UNH) opened at $243.35 on Wednesday. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group has a fifty-two week low of $156.49 and a fifty-two week high of $244.35. The company has a market cap of $235,290.00, a price-to-earnings ratio of 22.72, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period last year, the firm earned $2.11 EPS. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. equities research analysts anticipate that UnitedHealth Group will post 12.53 earnings per share for the current year.

In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now directly owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold a total of 33,655 shares of company stock valued at $7,469,083 over the last ninety days. 0.89% of the stock is currently owned by insiders.

A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. lifted its stake in UnitedHealth Group by 1.2% in the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the last quarter. Vanguard Group Inc. lifted its stake in UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the last quarter. FMR LLC lifted its stake in UnitedHealth Group by 2.1% in the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the last quarter. Alliancebernstein L.P. lifted its stake in UnitedHealth Group by 2.3% in the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after purchasing an additional 174,290 shares during the last quarter. Finally, TIAA CREF Investment Management LLC lifted its stake in UnitedHealth Group by 3.9% in the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after purchasing an additional 223,524 shares during the last quarter. 86.09% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group (UNH) PT Raised to $275.00” was reported by Daily Political and is owned by of Daily Political. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.dailypolitical.com/2018/01/20/unitedhealth-group-unh-pt-raised-to-275-00.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.